KADCYLA

Indicated For

Early breast cancer, metastatic breast cancer

About This Medication

# Genentech Oncology Co-pay Assistance Program Patient Guide: How to Get KADCYLA at Low or No Cost ## About KADCYLA KADCYLA (ado-trastuzumab emtansine) is a Genentech oncology medicine used to treat certain types of cancer. If your doctor has prescribed KADCYLA for an FDA-approved indication, financial assistance programs may be available to help you afford your medication, regardless of your current insurance situation. ## Who Can Get Help Genentech offers multiple pathways to assistance depending on your insurance coverage and financial situation: **If you have commercial (private) insurance:** The Genentech Oncology Co-pay Assistance Program can help reduce your out-of-pocket costs, including co-pays and co-insurance. **If you are uninsured or underinsured:** The Genentech Patient Foundation may provide free KADCYLA if you meet financial eligibility requirements. **If you have public insurance:** You may be referred to independent co-pay assistance foundations that support patients with government-funded plans. ## Insurance Requirements Understanding your insurance type is the first step in determining which program can help you. | Insurance Type | Eligible for Co-pay Program | Eligible for Patient Foundation | Next Steps | |---|---|---|---| | Commercial/Private (employer or marketplace) | Yes | Yes, if uninsured or without coverage | Call (855) 692-6729 | | Medicare | No | No | Contact Genentech Access Solutions | | Medicare Advantage | No | No | Contact Genentech Access Solutions | | Medicaid | No | Yes, if uninsured | Call (888) 941-3331 | | TRICARE | No | No | Contact Genentech Access Solutions | | VA | No | No | Contact Genentech Access Solutions | | Uninsured | No | Yes | Call (888) 941-3331 | **Important:** The Genentech Oncology Co-pay Assistance Program is **not available** for patients whose prescriptions are reimbursed under Medicare, Medicare Advantage, Medigap, Medicaid, TRICARE, VA, or other government-funded programs. ## Income Eligibility Income requirements vary depending on which program you apply for. The Genentech Patient Foundation has different financial thresholds for insured versus uninsured patients. To determine if you qualify based on your specific income and household size, you can: - Complete the Confirm Financial Eligibility form online - Call a Foundation Specialist at (888) 941-3331 (available Monday–Friday, 6 a.m.–5 p.m. ET) - Support is available in many different languages ## How to Apply ### For the Genentech Oncology Co-pay Assistance Program **Step 1: Gather Required Documents** - Your prescription for KADCYLA - Insurance information - Proof of income (if requested) **Step 2: Start Your Application** - Visit CopayAssistanceNow.com, or - Call (855) MY-COPAY at (855) 692-6729 (9 a.m.–8 p.m. ET, Monday–Friday, except major holidays) **Step 3: Complete Enrollment** - Follow the online enrollment process, or - A specialist can guide you through the application over the phone ### For the Genentech Patient Foundation **Step 1: Complete the Patient Consent Form** - Available online in English and Spanish - This form confirms you are applying for assistance **Step 2: Have Your Doctor Complete the Prescriber Foundation Form** - Your healthcare provider must complete this required form - Both forms are necessary to process your application **Step 3: Submit Both Forms** - Fax to: 833-999-4363, or - Text a photo to: 650-877-1111 **Step 4: Await Processing** - Your application will be reviewed within 5 business days of receiving both completed forms - Your doctor's office will be contacted to discuss the outcome and next steps Alternatively, if your healthcare provider has a registered account with My Patient Solutions, they can submit forms online through that portal. ## Timeline and Delivery **Application Processing:** Your application will typically be processed within 5 business days after both required forms are received. **Medicine Delivery:** Once approved, KADCYLA will be delivered through a specialty pharmacy. Your healthcare provider will coordinate the ordering and delivery process with you. **Ongoing Support:** You will need to reauthorize your assistance periodically to continue receiving support. Your healthcare provider or the assistance program will notify you when reauthorization is required. ## What Happens If Your Application Is Denied If you are denied assistance from one program, other options may still be available: - If denied by the Co-pay Assistance Program, ask about referrals to independent co-pay assistance foundations - If denied by the Patient Foundation, contact Genentech Access Solutions to explore other coverage options - Call (888) 249-4918 for KADCYLA Access Solutions to discuss alternative assistance pathways ## Important Restrictions **You are not eligible for the Genentech Patient Foundation if:** - Your health insurance plan or employer requires you to apply to a Patient Assistance Program as a condition of coverage for KADCYLA - Such requirements can interfere with timely treatment and create undue stress **You must:** - Be 18 years of age or older (or have a caregiver or legally authorized representative) - Have been prescribed KADCYLA for an FDA-approved indication - Meet all program eligibility criteria ## Questions or Need Help? **Genentech Oncology Co-pay Assistance Program:** - Phone: (855) 692-6729 (9 a.m.–8 p.m. ET, Monday–Friday) - Website: CopayAssistanceNow.com **Genentech Patient Foundation:** - Phone: (888) 941-3331 (6 a.m.–5 p.m. ET, Monday–Friday) - Website: GenentechPatientFoundation.com **KADCYLA Access Solutions:** - Phone: (888) 249-4918 Multilingual support is available. Your healthcare provider can also help guide you through the application process. ## Disclaimer Eligibility criteria and benefit limits apply. This guide provides general information about Genentech assistance programs. For complete terms, conditions, and the most current eligibility requirements, visit the program websites or contact the phone numbers listed above. Program details are subject to change. Always verify current requirements before applying.

Program information last verified: March 25, 2026